Please login to the form below

Not currently logged in

Glide Pharma appoints Mark Carnegie-Brown as CEO

Was formerly CEO of Evolutec and Aenova

Glide Pharma Mark Carnegie-BrownDr Mark Carnegie-Brown has joined Glide Pharma as CEO.

He brings more than 25 years of experience in the healthcare and life sciences industry to Glide - a development and device company focused on the needle-free administration of solid dose formulations.

His past experience includes five years as CEO of protein drug development company Evolutec from 2003 to 2008 and a year as CEO of contract manufacturing organisation Aenova from 2008 to 2009.

He also served as UK and Northern Europe managing director at Elsevier Health Sciences from 2009 to 2011 and managing director of Carbon Fibre Technologies International from November 2011.

“His research and commercial experience, and in particular his expertise in building successful clinical and manufacturing programmes, will prove invaluable as Glide scales up its capabilities and advances the development of its in-house programmes,” said Mark Kirby, chairman of Glide Pharma.

8th March 2013

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...